Akero Therapeutics Inc (AKRO)
20.79
+0.03
(+0.14%)
USD |
NASDAQ |
Apr 22, 16:00
20.78
-0.01
(-0.05%)
After-Hours: 20:00
Akero Therapeutics Cash from Investing (TTM): -223.62M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -223.62M |
| September 30, 2023 | -337.85M |
| June 30, 2023 | -209.16M |
| March 31, 2023 | -68.98M |
| December 31, 2022 | -63.82M |
| September 30, 2022 | 49.62M |
| June 30, 2022 | 68.55M |
| March 31, 2022 | 46.03M |
| December 31, 2021 | 42.28M |
| September 30, 2021 | 48.18M |
| Date | Value |
|---|---|
| June 30, 2021 | -33.60M |
| March 31, 2021 | 15.52M |
| December 31, 2020 | -9.761M |
| September 30, 2020 | -99.17M |
| June 30, 2020 | -39.33M |
| March 31, 2020 | -77.79M |
| December 31, 2019 | -71.51M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | -5.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-337.85M
Minimum
Sep 2023
68.55M
Maximum
Jun 2022
-50.76M
Average
-33.60M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -502.52M |
| 89bio Inc | -123.02M |
| Viking Therapeutics Inc | -179.09M |
| Eli Lilly and Co | -7.153B |
| Ionis Pharmaceuticals Inc | -214.13M |